カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗緑内障点眼薬の世界市場見通し2023年-2029年

◆英語タイトル：Anti Glaucoma Eyedrops Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5663）◆商品コード：MMG23JU5663
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：118
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anti Glaucoma Eyedrops Market 調査レポートは次の情報を含め、グローバルにおけるの抗緑内障点眼薬市場規模と予測を収録しています。・世界の抗緑内障点眼薬市場：売上、2018年-2023年、2024年-2029年
・世界の抗緑内障点眼薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗緑内障点眼薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ピロカルピン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗緑内障点眼薬のグローバル主要企業は、Novartis AG、 Allergan, Inc.、 Meda Pharmaceuticals Inc、 Bausch & Lomb Inc、 Cigna、 Similasan Corporation、 Visine、 Alcon、 Viva Opti-Free、 Bausch & Lomb、 Systane、 Rite Aid、 Walgreens、 Staples、 Clear eyesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗緑内障点眼薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗緑内障点眼薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗緑内障点眼薬市場：タイプ別市場シェア、2022年
・ピロカルピン、チモロール、ベトプティック、その他

世界の抗緑内障点眼薬市場：用途別、2018年-2023年、2024年-2029年
世界の抗緑内障点眼薬市場：用途別市場シェア、2022年
・大人、子供

世界の抗緑内障点眼薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗緑内障点眼薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗緑内障点眼薬のグローバル売上、2018年-2023年
・主要企業における抗緑内障点眼薬のグローバル売上シェア、2022年
・主要企業における抗緑内障点眼薬のグローバル販売量、2018年-2023年
・主要企業における抗緑内障点眼薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis AG、 Allergan, Inc.、 Meda Pharmaceuticals Inc、 Bausch & Lomb Inc、 Cigna、 Similasan Corporation、 Visine、 Alcon、 Viva Opti-Free、 Bausch & Lomb、 Systane、 Rite Aid、 Walgreens、 Staples、 Clear eyes

*************************************************************

・調査・分析レポートの概要
抗緑内障点眼薬市場の定義
市場セグメント
世界の抗緑内障点眼薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗緑内障点眼薬市場規模
世界の抗緑内障点眼薬市場規模：2022年 VS 2029年
世界の抗緑内障点眼薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗緑内障点眼薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗緑内障点眼薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ピロカルピン、チモロール、ベトプティック、その他
抗緑内障点眼薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：大人、子供
抗緑内障点眼薬の用途別グローバル売上・予測

・地域別市場分析
地域別抗緑内障点眼薬市場規模 2022年と2029年
地域別抗緑内障点眼薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis AG、 Allergan, Inc.、 Meda Pharmaceuticals Inc、 Bausch & Lomb Inc、 Cigna、 Similasan Corporation、 Visine、 Alcon、 Viva Opti-Free、 Bausch & Lomb、 Systane、 Rite Aid、 Walgreens、 Staples、 Clear eyes
...

This report aims to provide a comprehensive presentation of the global market for Anti Glaucoma Eyedrops, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Glaucoma Eyedrops. This report contains market size and forecasts of Anti Glaucoma Eyedrops in global, including the following market information:
Global Anti Glaucoma Eyedrops Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti Glaucoma Eyedrops Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti Glaucoma Eyedrops companies in 2022 (%)
The global Anti Glaucoma Eyedrops market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pilocarpine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti Glaucoma Eyedrops include Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon and Viva Opti-Free, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti Glaucoma Eyedrops manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti Glaucoma Eyedrops Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Glaucoma Eyedrops Market Segment Percentages, by Type, 2022 (%)
Pilocarpine
Timolol
Betoptic
Others
Global Anti Glaucoma Eyedrops Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Glaucoma Eyedrops Market Segment Percentages, by Application, 2022 (%)
Adult
Children
Global Anti Glaucoma Eyedrops Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Glaucoma Eyedrops Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti Glaucoma Eyedrops revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti Glaucoma Eyedrops revenues share in global market, 2022 (%)
Key companies Anti Glaucoma Eyedrops sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti Glaucoma Eyedrops sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti Glaucoma Eyedrops, market overview.
Chapter 2: Global Anti Glaucoma Eyedrops market size in revenue and volume.
Chapter 3: Detailed analysis of Anti Glaucoma Eyedrops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti Glaucoma Eyedrops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti Glaucoma Eyedrops capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anti Glaucoma Eyedrops Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti Glaucoma Eyedrops Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti Glaucoma Eyedrops Overall Market Size
2.1 Global Anti Glaucoma Eyedrops Market Size: 2022 VS 2029
2.2 Global Anti Glaucoma Eyedrops Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti Glaucoma Eyedrops Sales: 2018-2029
3 Company Landscape
3.1 Top Anti Glaucoma Eyedrops Players in Global Market
3.2 Top Global Anti Glaucoma Eyedrops Companies Ranked by Revenue
3.3 Global Anti Glaucoma Eyedrops Revenue by Companies
3.4 Global Anti Glaucoma Eyedrops Sales by Companies
3.5 Global Anti Glaucoma Eyedrops Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti Glaucoma Eyedrops Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti Glaucoma Eyedrops Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti Glaucoma Eyedrops Players in Global Market
3.8.1 List of Global Tier 1 Anti Glaucoma Eyedrops Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti Glaucoma Eyedrops Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti Glaucoma Eyedrops Market Size Markets, 2022 & 2029
4.1.2 Pilocarpine
4.1.3 Timolol
4.1.4 Betoptic
4.1.5 Others
4.2 By Type – Global Anti Glaucoma Eyedrops Revenue & Forecasts
4.2.1 By Type – Global Anti Glaucoma Eyedrops Revenue, 2018-2023
4.2.2 By Type – Global Anti Glaucoma Eyedrops Revenue, 2024-2029
4.2.3 By Type – Global Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
4.3 By Type – Global Anti Glaucoma Eyedrops Sales & Forecasts
4.3.1 By Type – Global Anti Glaucoma Eyedrops Sales, 2018-2023
4.3.2 By Type – Global Anti Glaucoma Eyedrops Sales, 2024-2029
4.3.3 By Type – Global Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
4.4 By Type – Global Anti Glaucoma Eyedrops Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti Glaucoma Eyedrops Market Size, 2022 & 2029
5.1.2 Adult
5.1.3 Children
5.2 By Application – Global Anti Glaucoma Eyedrops Revenue & Forecasts
5.2.1 By Application – Global Anti Glaucoma Eyedrops Revenue, 2018-2023
5.2.2 By Application – Global Anti Glaucoma Eyedrops Revenue, 2024-2029
5.2.3 By Application – Global Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
5.3 By Application – Global Anti Glaucoma Eyedrops Sales & Forecasts
5.3.1 By Application – Global Anti Glaucoma Eyedrops Sales, 2018-2023
5.3.2 By Application – Global Anti Glaucoma Eyedrops Sales, 2024-2029
5.3.3 By Application – Global Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
5.4 By Application – Global Anti Glaucoma Eyedrops Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anti Glaucoma Eyedrops Market Size, 2022 & 2029
6.2 By Region – Global Anti Glaucoma Eyedrops Revenue & Forecasts
6.2.1 By Region – Global Anti Glaucoma Eyedrops Revenue, 2018-2023
6.2.2 By Region – Global Anti Glaucoma Eyedrops Revenue, 2024-2029
6.2.3 By Region – Global Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
6.3 By Region – Global Anti Glaucoma Eyedrops Sales & Forecasts
6.3.1 By Region – Global Anti Glaucoma Eyedrops Sales, 2018-2023
6.3.2 By Region – Global Anti Glaucoma Eyedrops Sales, 2024-2029
6.3.3 By Region – Global Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anti Glaucoma Eyedrops Revenue, 2018-2029
6.4.2 By Country – North America Anti Glaucoma Eyedrops Sales, 2018-2029
6.4.3 US Anti Glaucoma Eyedrops Market Size, 2018-2029
6.4.4 Canada Anti Glaucoma Eyedrops Market Size, 2018-2029
6.4.5 Mexico Anti Glaucoma Eyedrops Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anti Glaucoma Eyedrops Revenue, 2018-2029
6.5.2 By Country – Europe Anti Glaucoma Eyedrops Sales, 2018-2029
6.5.3 Germany Anti Glaucoma Eyedrops Market Size, 2018-2029
6.5.4 France Anti Glaucoma Eyedrops Market Size, 2018-2029
6.5.5 U.K. Anti Glaucoma Eyedrops Market Size, 2018-2029
6.5.6 Italy Anti Glaucoma Eyedrops Market Size, 2018-2029
6.5.7 Russia Anti Glaucoma Eyedrops Market Size, 2018-2029
6.5.8 Nordic Countries Anti Glaucoma Eyedrops Market Size, 2018-2029
6.5.9 Benelux Anti Glaucoma Eyedrops Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anti Glaucoma Eyedrops Revenue, 2018-2029
6.6.2 By Region – Asia Anti Glaucoma Eyedrops Sales, 2018-2029
6.6.3 China Anti Glaucoma Eyedrops Market Size, 2018-2029
6.6.4 Japan Anti Glaucoma Eyedrops Market Size, 2018-2029
6.6.5 South Korea Anti Glaucoma Eyedrops Market Size, 2018-2029
6.6.6 Southeast Asia Anti Glaucoma Eyedrops Market Size, 2018-2029
6.6.7 India Anti Glaucoma Eyedrops Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anti Glaucoma Eyedrops Revenue, 2018-2029
6.7.2 By Country – South America Anti Glaucoma Eyedrops Sales, 2018-2029
6.7.3 Brazil Anti Glaucoma Eyedrops Market Size, 2018-2029
6.7.4 Argentina Anti Glaucoma Eyedrops Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti Glaucoma Eyedrops Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anti Glaucoma Eyedrops Sales, 2018-2029
6.8.3 Turkey Anti Glaucoma Eyedrops Market Size, 2018-2029
6.8.4 Israel Anti Glaucoma Eyedrops Market Size, 2018-2029
6.8.5 Saudi Arabia Anti Glaucoma Eyedrops Market Size, 2018-2029
6.8.6 UAE Anti Glaucoma Eyedrops Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Anti Glaucoma Eyedrops Major Product Offerings
7.1.4 Novartis AG Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Allergan, Inc.
7.2.1 Allergan, Inc. Company Summary
7.2.2 Allergan, Inc. Business Overview
7.2.3 Allergan, Inc. Anti Glaucoma Eyedrops Major Product Offerings
7.2.4 Allergan, Inc. Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.2.5 Allergan, Inc. Key News & Latest Developments
7.3 Meda Pharmaceuticals Inc
7.3.1 Meda Pharmaceuticals Inc Company Summary
7.3.2 Meda Pharmaceuticals Inc Business Overview
7.3.3 Meda Pharmaceuticals Inc Anti Glaucoma Eyedrops Major Product Offerings
7.3.4 Meda Pharmaceuticals Inc Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.3.5 Meda Pharmaceuticals Inc Key News & Latest Developments
7.4 Bausch & Lomb Inc
7.4.1 Bausch & Lomb Inc Company Summary
7.4.2 Bausch & Lomb Inc Business Overview
7.4.3 Bausch & Lomb Inc Anti Glaucoma Eyedrops Major Product Offerings
7.4.4 Bausch & Lomb Inc Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.4.5 Bausch & Lomb Inc Key News & Latest Developments
7.5 Cigna
7.5.1 Cigna Company Summary
7.5.2 Cigna Business Overview
7.5.3 Cigna Anti Glaucoma Eyedrops Major Product Offerings
7.5.4 Cigna Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.5.5 Cigna Key News & Latest Developments
7.6 Similasan Corporation
7.6.1 Similasan Corporation Company Summary
7.6.2 Similasan Corporation Business Overview
7.6.3 Similasan Corporation Anti Glaucoma Eyedrops Major Product Offerings
7.6.4 Similasan Corporation Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.6.5 Similasan Corporation Key News & Latest Developments
7.7 Visine
7.7.1 Visine Company Summary
7.7.2 Visine Business Overview
7.7.3 Visine Anti Glaucoma Eyedrops Major Product Offerings
7.7.4 Visine Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.7.5 Visine Key News & Latest Developments
7.8 Alcon
7.8.1 Alcon Company Summary
7.8.2 Alcon Business Overview
7.8.3 Alcon Anti Glaucoma Eyedrops Major Product Offerings
7.8.4 Alcon Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.8.5 Alcon Key News & Latest Developments
7.9 Viva Opti-Free
7.9.1 Viva Opti-Free Company Summary
7.9.2 Viva Opti-Free Business Overview
7.9.3 Viva Opti-Free Anti Glaucoma Eyedrops Major Product Offerings
7.9.4 Viva Opti-Free Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.9.5 Viva Opti-Free Key News & Latest Developments
7.10 Bausch & Lomb
7.10.1 Bausch & Lomb Company Summary
7.10.2 Bausch & Lomb Business Overview
7.10.3 Bausch & Lomb Anti Glaucoma Eyedrops Major Product Offerings
7.10.4 Bausch & Lomb Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.10.5 Bausch & Lomb Key News & Latest Developments
7.11 Systane
7.11.1 Systane Company Summary
7.11.2 Systane Anti Glaucoma Eyedrops Business Overview
7.11.3 Systane Anti Glaucoma Eyedrops Major Product Offerings
7.11.4 Systane Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.11.5 Systane Key News & Latest Developments
7.12 Rite Aid
7.12.1 Rite Aid Company Summary
7.12.2 Rite Aid Anti Glaucoma Eyedrops Business Overview
7.12.3 Rite Aid Anti Glaucoma Eyedrops Major Product Offerings
7.12.4 Rite Aid Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.12.5 Rite Aid Key News & Latest Developments
7.13 Walgreens
7.13.1 Walgreens Company Summary
7.13.2 Walgreens Anti Glaucoma Eyedrops Business Overview
7.13.3 Walgreens Anti Glaucoma Eyedrops Major Product Offerings
7.13.4 Walgreens Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.13.5 Walgreens Key News & Latest Developments
7.14 Staples
7.14.1 Staples Company Summary
7.14.2 Staples Business Overview
7.14.3 Staples Anti Glaucoma Eyedrops Major Product Offerings
7.14.4 Staples Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.14.5 Staples Key News & Latest Developments
7.15 Clear eyes
7.15.1 Clear eyes Company Summary
7.15.2 Clear eyes Business Overview
7.15.3 Clear eyes Anti Glaucoma Eyedrops Major Product Offerings
7.15.4 Clear eyes Anti Glaucoma Eyedrops Sales and Revenue in Global (2018-2023)
7.15.5 Clear eyes Key News & Latest Developments
8 Global Anti Glaucoma Eyedrops Production Capacity, Analysis
8.1 Global Anti Glaucoma Eyedrops Production Capacity, 2018-2029
8.2 Anti Glaucoma Eyedrops Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti Glaucoma Eyedrops Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti Glaucoma Eyedrops Supply Chain Analysis
10.1 Anti Glaucoma Eyedrops Industry Value Chain
10.2 Anti Glaucoma Eyedrops Upstream Market
10.3 Anti Glaucoma Eyedrops Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti Glaucoma Eyedrops Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Anti Glaucoma Eyedrops in Global Market
Table 2. Top Anti Glaucoma Eyedrops Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti Glaucoma Eyedrops Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti Glaucoma Eyedrops Revenue Share by Companies, 2018-2023
Table 5. Global Anti Glaucoma Eyedrops Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti Glaucoma Eyedrops Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti Glaucoma Eyedrops Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti Glaucoma Eyedrops Product Type
Table 9. List of Global Tier 1 Anti Glaucoma Eyedrops Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti Glaucoma Eyedrops Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti Glaucoma Eyedrops Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti Glaucoma Eyedrops Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti Glaucoma Eyedrops Sales (K Units), 2018-2023
Table 15. By Type - Global Anti Glaucoma Eyedrops Sales (K Units), 2024-2029
Table 16. By Application – Global Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti Glaucoma Eyedrops Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti Glaucoma Eyedrops Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti Glaucoma Eyedrops Sales (K Units), 2018-2023
Table 20. By Application - Global Anti Glaucoma Eyedrops Sales (K Units), 2024-2029
Table 21. By Region – Global Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti Glaucoma Eyedrops Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti Glaucoma Eyedrops Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti Glaucoma Eyedrops Sales (K Units), 2018-2023
Table 25. By Region - Global Anti Glaucoma Eyedrops Sales (K Units), 2024-2029
Table 26. By Country - North America Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti Glaucoma Eyedrops Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti Glaucoma Eyedrops Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti Glaucoma Eyedrops Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti Glaucoma Eyedrops Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti Glaucoma Eyedrops Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti Glaucoma Eyedrops Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti Glaucoma Eyedrops Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti Glaucoma Eyedrops Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti Glaucoma Eyedrops Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti Glaucoma Eyedrops Sales, (K Units), 2024-2029
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Anti Glaucoma Eyedrops Product Offerings
Table 48. Novartis AG Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Allergan, Inc. Company Summary
Table 51. Allergan, Inc. Anti Glaucoma Eyedrops Product Offerings
Table 52. Allergan, Inc. Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Allergan, Inc. Key News & Latest Developments
Table 54. Meda Pharmaceuticals Inc Company Summary
Table 55. Meda Pharmaceuticals Inc Anti Glaucoma Eyedrops Product Offerings
Table 56. Meda Pharmaceuticals Inc Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Meda Pharmaceuticals Inc Key News & Latest Developments
Table 58. Bausch & Lomb Inc Company Summary
Table 59. Bausch & Lomb Inc Anti Glaucoma Eyedrops Product Offerings
Table 60. Bausch & Lomb Inc Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Bausch & Lomb Inc Key News & Latest Developments
Table 62. Cigna Company Summary
Table 63. Cigna Anti Glaucoma Eyedrops Product Offerings
Table 64. Cigna Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Cigna Key News & Latest Developments
Table 66. Similasan Corporation Company Summary
Table 67. Similasan Corporation Anti Glaucoma Eyedrops Product Offerings
Table 68. Similasan Corporation Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Similasan Corporation Key News & Latest Developments
Table 70. Visine Company Summary
Table 71. Visine Anti Glaucoma Eyedrops Product Offerings
Table 72. Visine Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Visine Key News & Latest Developments
Table 74. Alcon Company Summary
Table 75. Alcon Anti Glaucoma Eyedrops Product Offerings
Table 76. Alcon Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Alcon Key News & Latest Developments
Table 78. Viva Opti-Free Company Summary
Table 79. Viva Opti-Free Anti Glaucoma Eyedrops Product Offerings
Table 80. Viva Opti-Free Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Viva Opti-Free Key News & Latest Developments
Table 82. Bausch & Lomb Company Summary
Table 83. Bausch & Lomb Anti Glaucoma Eyedrops Product Offerings
Table 84. Bausch & Lomb Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Bausch & Lomb Key News & Latest Developments
Table 86. Systane Company Summary
Table 87. Systane Anti Glaucoma Eyedrops Product Offerings
Table 88. Systane Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Systane Key News & Latest Developments
Table 90. Rite Aid Company Summary
Table 91. Rite Aid Anti Glaucoma Eyedrops Product Offerings
Table 92. Rite Aid Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Rite Aid Key News & Latest Developments
Table 94. Walgreens Company Summary
Table 95. Walgreens Anti Glaucoma Eyedrops Product Offerings
Table 96. Walgreens Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Walgreens Key News & Latest Developments
Table 98. Staples Company Summary
Table 99. Staples Anti Glaucoma Eyedrops Product Offerings
Table 100. Staples Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Staples Key News & Latest Developments
Table 102. Clear eyes Company Summary
Table 103. Clear eyes Anti Glaucoma Eyedrops Product Offerings
Table 104. Clear eyes Anti Glaucoma Eyedrops Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Clear eyes Key News & Latest Developments
Table 106. Anti Glaucoma Eyedrops Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Anti Glaucoma Eyedrops Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Anti Glaucoma Eyedrops Production by Region, 2018-2023 (K Units)
Table 109. Global Anti Glaucoma Eyedrops Production by Region, 2024-2029 (K Units)
Table 110. Anti Glaucoma Eyedrops Market Opportunities & Trends in Global Market
Table 111. Anti Glaucoma Eyedrops Market Drivers in Global Market
Table 112. Anti Glaucoma Eyedrops Market Restraints in Global Market
Table 113. Anti Glaucoma Eyedrops Raw Materials
Table 114. Anti Glaucoma Eyedrops Raw Materials Suppliers in Global Market
Table 115. Typical Anti Glaucoma Eyedrops Downstream
Table 116. Anti Glaucoma Eyedrops Downstream Clients in Global Market
Table 117. Anti Glaucoma Eyedrops Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti Glaucoma Eyedrops Segment by Type in 2022
Figure 2. Anti Glaucoma Eyedrops Segment by Application in 2022
Figure 3. Global Anti Glaucoma Eyedrops Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti Glaucoma Eyedrops Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti Glaucoma Eyedrops Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti Glaucoma Eyedrops Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti Glaucoma Eyedrops Revenue in 2022
Figure 9. By Type - Global Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti Glaucoma Eyedrops Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti Glaucoma Eyedrops Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti Glaucoma Eyedrops Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
Figure 23. US Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
Figure 28. Germany Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
Figure 37. China Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
Figure 44. Brazil Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti Glaucoma Eyedrops Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti Glaucoma Eyedrops Sales Market Share, 2018-2029
Figure 48. Turkey Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti Glaucoma Eyedrops Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti Glaucoma Eyedrops Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti Glaucoma Eyedrops by Region, 2022 VS 2029
Figure 54. Anti Glaucoma Eyedrops Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 抗緑内障点眼薬の世界市場見通し2023年-2029年(Anti Glaucoma Eyedrops Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 抗炎症抗生物質点眼薬の世界市場見通し2023年-2029年
  • 副腎皮質ステロイド点眼薬の世界市場見通し2023年-2029年
  • 緑内障用レーザー装置の世界市場見通し2023年-2029年
  • 緑内障治療薬の世界市場見通し2023年-2029年
  • 緑内障治療装置の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆